DNPUF
Price:
$4.3
Market Cap:
$260.43B
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In additio...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-01-17
Stock Exchange
PNK
Ticker
DNPUF
According to Sumitomo Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.94. This represents a change of 628.41% compared to the average of -0.13 of the last 4 quarters.
The mean historical PE Ratio of Sumitomo Pharma Co., Ltd. over the last ten years is 14.18. The current -0.94 PE Ratio has changed -763.07% with respect to the historical average. Over the past ten years (40 quarters), DNPUF's PE Ratio was at its highest in in the March 2016 quarter at 89.72. The PE Ratio was at its lowest in in the March 2017 quarter at -316.58.
Average
14.18
Median
14.20
Minimum
-4.52
Maximum
30.86
Discovering the peaks and valleys of Sumitomo Pharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 101.01%
Maximum Annual PE Ratio = 30.86
Minimum Annual Increase = -151.57%
Minimum Annual PE Ratio = -4.52
Year | PE Ratio | Change |
---|---|---|
2024 | -0.50 | -88.99% |
2023 | -4.52 | -151.57% |
2022 | 8.76 | -40.29% |
2021 | 14.66 | 6.82% |
2020 | 13.73 | -42.36% |
2019 | 23.82 | 101.01% |
2018 | 11.85 | -49.48% |
2017 | 23.45 | 19.38% |
2016 | 19.65 | -36.35% |
2015 | 30.86 | -6.52% |
The current PE Ratio of Sumitomo Pharma Co., Ltd. (DNPUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.25
5-year avg
6.43
10-year avg
14.18
Sumitomo Pharma Co., Ltd.’s PE Ratio is less than Hypera S.A. (8.36), greater than Indivior PLC (-546.89), less than YourWay Cannabis Brands Inc. (0), greater than Cumberland Pharmaceuticals Inc. (-1.55), less than RAMM Pharma Corp. (0), less than Genomma Lab Internacional, S.A.B. de C.V. (1.50), less than Speakeasy Cannabis Club Ltd. (-0.00), greater than City View Green Holdings Inc. (-1.53), less than Craftport Cannabis Corp. (-0.01), greater than Orexo AB (publ) (-4.68), greater than Indivior PLC (-546.89), greater than C21 Investments Inc. (-5.79), less than RavenQuest BioMed Inc. (-0.00), less than Bhang Inc. (-0.01), greater than Willow Biosciences Inc. (-1.28), greater than Alpha Teknova, Inc. (-8.25), less than Guardion Health Sciences, Inc. (-0.70), less than Lifecore Biomedical, Inc. (28.27), greater than Organogenesis Holdings Inc. (-52.13), less than Petros Pharmaceuticals, Inc. (-0.19),
Company | PE Ratio | Market cap |
---|---|---|
8.36 | $2.44B | |
-546.89 | $2.89B | |
0 | $17.82M | |
-1.55 | $16.07M | |
0 | $15.16M | |
1.50 | $1.15B | |
-0.00 | $1.31K | |
-1.53 | $1.92M | |
-0.01 | $6.48B | |
-4.68 | $38.58M | |
-546.89 | $3.01B | |
-5.79 | $24.66M | |
-0.00 | $482.11K | |
-0.01 | $23.48K | |
-1.28 | $9.06M | |
-8.25 | $368.86M | |
-0.70 | $4.35M | |
28.27 | $220.59M | |
-52.13 | $396.40M | |
-0.19 | $3.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sumitomo Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sumitomo Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sumitomo Pharma Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the highest PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the 3-year average PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?
What is the 5-year average PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF)?
How does the current PE Ratio for Sumitomo Pharma Co., Ltd. (DNPUF) compare to its historical average?